Waterdrop (NYSE: WDH) concluded its fiscal year 2025 with remarkable financial achievements, largely attributed to its expanding insurance business and comprehensive integration of artificial intelligence. The company not only maintained GAAP profitability for an impressive 16 consecutive quarters but also substantially enhanced shareholder value through consistent dividends and a robust share repurchase program. This period also saw significant advancements in product offerings and technological upgrades across its insurance, medical crowdfunding, and digital clinical trial services, reinforcing its market position.
Waterdrop's Financial and Strategic Triumphs in Fiscal Year 2025
In a recent announcement, Waterdrop's executives unveiled a period of substantial financial and operational success for fiscal year 2025. Founder, Chairman, and CEO Shen Peng underscored the profound impact of their 'AI plus insurance' strategy, which propelled both top-line and bottom-line expansion. The company reported a total revenue of CNY 3.98 billion, marking a significant 43.5% increase year-over-year. Net profit attributable to ordinary shareholders surged by 64.8% to CNY 570 million, demonstrating strong financial health. Adding to these impressive figures, Waterdrop ended the fiscal year with a solid cash reserve of approximately CNY 3.25 billion.
Xiaoying Xu, the Head of Finance, elaborated on the fourth-quarter performance, noting an extraordinary 105.5% increase in revenue, reaching CNY 1.41 billion. Net profit for the quarter also saw a healthy rise of 52.7%, totaling CNY 152 million. The insurance segment emerged as the primary growth engine, with its revenue climbing by 61.3% and achieving an operating margin of roughly 18%. Full-year insurance-related income stood at approximately CNY 3.58 billion, a 51.3% jump from the previous year, while other business segments contributed about 10.1% to the total revenue.
Wei Ran, Director and General Manager of the insurance division, highlighted the sustained momentum in the fourth quarter, particularly in insurance-related income, which soared by 125% year-over-year to CNY 1.31 billion. Operating profit for the division increased by 42% to CNY 160 million. Wei detailed how AI is intricately woven into every facet of their service delivery. The 'AI Pro Insurance agent' on their mini-program led to a 33% sequential boost in premiums, while 'AI medical insurance experts' generated over CNY 50 million in first-year premiums (FYT), a remarkable 145% quarter-over-quarter increase. Furthermore, the 'Life Planner Copilot' assisted in over 370,000 inquiries, and 'AI customer service agents' efficiently handled over 1.4 million inquiries monthly, achieving 2.75 times the efficiency of manual operations.
In terms of product innovation, Waterdrop launched version 2.0 of its offerings, introducing 'zero deductible' features for long-term and routine medical expenses. A pre-existing condition product also saw significant uptake, contributing nearly 70% of first-year premiums, and disability insurance added approximately CNY 100 million in FYT. The company’s WeChat CDOT AI platform, now fully operational with core modules like workflow agents and batch testing, has been made accessible to partners, including other insurers.
Beyond insurance, Waterdrop's medical crowdfunding platform continued to expand its reach, with nearly 490 million individuals collectively donating CNY 72.3 billion to support 3.68 million patients by the end of 2025. The company also reinforced its risk management protocols, utilizing large language models for real-time dynamic masking of sensitive data and deploying advanced models to verify authenticity and combat fraudulent claims, ensuring privacy and content integrity.
In healthcare, Waterdrop advanced its digital clinical trial services. The integration of LLMs significantly enhanced its medical performance platform, which has engaged with 3.68 million patients since its inception. The digital clinical trial solutions successfully enrolled over 4,000 patients within the year. The E-Find platform, collaborating with 224 pharmaceutical companies, enrolled a cumulative 14,055 patients and initiated 131 new programs. The company also secured a national invention patent in China for its proprietary E-Find patient matching technology, which leverages deep neural networks and natural language processing to drastically reduce patient screening workloads.
On the technological front, Shen Peng reiterated Waterdrop's commitment to becoming an "AI-native" enterprise, with 72 LLM-related patent applications filed by the end of 2023, including nine international filings. The company rolled out a multi-modal AI agent supporting text, voice, and virtual interactions across various workflows, unified under the 'Waterdrop C AI platform,' now open to industry partners. An innovative collaborative 'Guardian AI Copilot' named CloudSphere is also under development, designed for autonomous communication between AI agents.
Addressing shareholder returns, the board approved a fifth cash dividend of $0.03 per ADS, totaling $10.8 million, payable to shareholders of record by April 24, 2024. The company's share repurchase program also saw 60.7 million ADSs repurchased for approximately $118 million by the end of February 2024.
Despite a rise in fourth-quarter operating costs to CNY 680 million (up 109.2% year-over-year) due to increased referral, service, and SMS fees, Waterdrop is strategically investing in its future. Sales and marketing expenses increased by 178.4% to CNY 510 million, reflecting scaled investment in third-party traffic channels and improved customer acquisition efficiency. General and administrative expenses saw a modest rise of 4.6% to CNY 77.1 million, and research and development expenses increased by 21.9% to CNY 66.2 million. Looking ahead, Waterdrop anticipates maintaining strong momentum with "moderately higher investment in marketing and AI," targeting double-digit growth in both revenue and profit.
Waterdrop's journey showcases a profound transformation fueled by strategic foresight and technological prowess. Their seamless integration of AI into every operational layer has not only revolutionized their service delivery but also set new benchmarks for efficiency and customer engagement in the insurtech sector. The company's unwavering commitment to innovation, coupled with a robust financial performance, positions it as a formidable leader in the digital insurance and healthcare landscape. This success story serves as an inspiring example of how embracing cutting-edge technology can unlock unprecedented growth and reshape industries, benefiting both the company and its stakeholders.